Alpha Cognition Inc., a clinical stage biopharmaceutical company, engages in the development of treatments for Alzheimer’s disease and amyotrophic lateral sclerosis (ALS). The company offers ...

Its lead gene therapy product candidates include AMI-101 for the treatment or prevention of Alzheimer’s disease; and AMI-202 to treat and prevent amyotrophic lateral sclerosis. The company was ...

A new study found that a gene recently recognized as a biomarker for Alzheimer's disease is actually a cause of it, due to its previously unknown secondary function that triggers a pathway that ...

People with Alzheimer's disease may retain their ability to empathize, despite declines in other social abilities, finds a new study.

Brain tissue analysis of an animal model has revealed the potential role of immune system dysfunction in the onset and ...

Alzheimer’s disease is commonly thought of as an older person’s illness. But new research from Columbia University and the University of North Carolina reveals early signs of Alzheimer’s ...

According to the Mayo Clinic, Alzheimer’s is a degenerative disease that destroys brain cells, called neurons. It was first ...

The outlook on the prevention, diagnosis and treatment of Alzheimer’s disease is brighter than ever. Backed by decades of ...

A new study found that a gene recently recognized as a biomarker for Alzheimer's disease is actually a cause of it, due to its previously unknown secondary function.

AI model reveals the structural secrets of misfolded proteins. A new artificial intelligence (AI) tool has provided critical ...

SALT LAKE CITY — A new blood test used to detect the pathology of Alzheimer’s Disease has just launched in Utah, and local experts are calling it revolutionary. The pTau 217 Blood Test is ...